Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
549 13, 549 60, 549214, 549414, C07D307935
The present invention describes 5-fluoro-3-oxa-prostacyclin (PGI.sub.2) derivatives of Formula I. These compounds are useful for the treatment of platelet dysfunction, atherosclerosis, hypertension and tumor cell metastasis. Also disclosed is the process for preparing them and the appropriate intermediates. ##STR1## wherein R.sup.1 is: (a) Na, K, or 1/2 Ca, or other pharmaceutically acceptable cation
patent: 4324730 (1982-04-01), Fried
Mitra, The Synthesis of Prostaglandins, Wiley (1977), pp. 236-237, 318-319 and 386-387.
Chinn Leland J.
Djuric Stevan W.
Rorig Kurt J.
Benson Robert H.
Dentz Bernard I.
G. D. Searle & Co.
Jiles Henry R.
5-fluoro-3-oxa-6,7-didehydro-PGI.sub.1 compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.If you have personal experience with 5-fluoro-3-oxa-6,7-didehydro-PGI.sub.1 compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5-fluoro-3-oxa-6,7-didehydro-PGI.sub.1 compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1085590